C. González-Bello obtained her PhD at the University of Santiago de Compostela (USC, Spain) in 1994. During her PhD studies, she did two predoctoral stays, first in the University of Gent (Belgium, 1991) with Prof. M. Vandewalle and then in the Scripps Research Institute (La Jolla, USA, 1992) with Prof. K. C. Nicolaou. After a postdoctoral stay as an EC-fellow in the University of Cambridge (UK) with Prof. Chris Abell (1994-96), she joined the USC as an Assistant Professor in 1996, was promoted to Associate Professor in 2003 and obtained the Spanish habilitation to full Professor in 2011. She joined the CIQUS as a group leader in 2011. She is author of about 90 scientific articles in peer-reviewed journals, 14 chapters in books and three European patents. She is an academic editor of the international journal “PLOS ONE” (2015-), and also member of the International Advisory Board of Advanced Therapeutics (2018-), ACS Omega (2021-) and ChemMedChem (2010-2020). Since February 2011, she is the treasurer of the Chemical Biology group of the Spanish Royal Society of Chemistry. She is one of the managers of the Spanish State Research Agency (AEI), in the subarea "Chemical Sciences and Technologies (CTQ, 2019-). Her main research interest is to develop updated therapies targeting infectious diseases, in particular, drugs with new mechanisms of action. She is an expert in the structure-, motion- and mechanism-based design of compounds and in computational biology.